Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth - Aix-Marseille Université Access content directly
Journal Articles Journal of Clinical Investigation Year : 2015

Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth

Coralie Hoareau-Aveilla
  • Function : Author
  • PersonId : 837547
Thibaud Valentin
  • Function : Author
Camille Daugrois
  • Function : Author
Cathy Quelen
  • Function : Author
Géraldine Mitou
  • Function : Author
Samuel Quentin
Jinsong Jia
  • Function : Author
Monica Ceccon
  • Function : Author
Sylvie Giuriato
  • Function : Author
Carlo Gambacorti-Passerini
  • Function : Author
Laurence Lamant
  • Function : Author
Fabienne Meggetto

Abstract

no abstract

Dates and versions

hal-01614947 , version 1 (11-10-2017)

Identifiers

Cite

Coralie Hoareau-Aveilla, Thibaud Valentin, Camille Daugrois, Cathy Quelen, Géraldine Mitou, et al.. Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth. Journal of Clinical Investigation, 2015, 125 (9), pp.3505--3518. ⟨10.1172/JCI78488⟩. ⟨hal-01614947⟩
57 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More